National University Hospital, Singapore: Nasopharyngeal Carcinoma trials

The registry lists 13 Nasopharyngeal Carcinoma studies with National University Hospital, Singapore as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 7No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck CancersNot yet recruitingNCT07674706Not applicable
• Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal CarcinomaNot yet recruitingNCT07565389Phase 2
• Screening for Early Diagnosis of Nose CancerRecruitingNCT07019870Not applicable
• ChemoRT With and Without Dental Stent for Taste Protection in NPC PatientsRecruitingNCT06733948Phase 2
• A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04627961Phase 2
• Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPCActive, not recruitingNCT03813394Phase 1/2
• Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT03282617Phase 1
• Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
• OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive ChemoradiotherapyTerminatedNCT02058017Phase 1
• Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
• A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal CancerStatus unknownNCT00943891
• A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal CarcinomaCompletedNCT00717184Phase 1
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2